A review of contact dermatitis associated with transdermal therapeutic systems.
The literature is reviewed for contact dermatitis associated with transdermal therapeutic systems. Clonidine, nitroglycerin, scopolamine, estradiol and testosterone are utilized in such applications, and fentanyl is under investigation. Most cutaneous reactions are limited to localized dermatitis; however, generalized systemic effects may occur. Investigators are reporting skin-related side-effects in up to 50% of patients using transdermal clonidine; however, with the other agents, this is demonstrated much less frequently. Reactivation of the dermatitis via oral medication, following sensitization to the patch, is noted in rare instances.
Holdiness
M R
MR
Lakeside Hospital, Metairie (New Orleans), Louisiana 70001-9043.
D000279:Administration, Cutaneous; D000284:Administration, Oral; D003000:Clonidine / Q000008:administration & dosage / Q000009:adverse effects; D003877:Dermatitis, Contact / Q000209:etiology* / Q000276:immunology; D004958:Estradiol / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D005996:Nitroglycerin / Q000008:administration & dosage / Q000009:adverse effects; D012601:Scopolamine / Q000008:administration & dosage / Q000009:adverse effects; D013739:Testosterone / Q000008:administration & dosage / Q000009:adverse effects; D013997:Time Factors
D013739:Testosterone; D004958:Estradiol; D012601:Scopolamine; D005996:Nitroglycerin; D003000:Clonidine